Top Banner
Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver
60

Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Dec 23, 2015

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Michael P. Federle, MDAssociate Chair for Education

Department of Radiology

Stanford University

Focal Lesions in the Cirrhotic Liver

Page 2: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Focal Lesions in the Cirrhotic Liver

• Cysts, hemangiomas, focal fat, confluent fibrosis– Can usually be diagnosed accurately

• Hemangiomas shrink and become sclerosed in cirrhotic liver– Often not identified in advanced cirrhosis

• Focal fat– Key is out-of-phase MR (focal sign dropout)

Brancatelli et al. Radiology 2001; 219: 69-74

Page 3: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

RN

NECT Enhancement

Cysts Hypodense No

RN Hyperdense Minimal

Cysts + Regenerative Nodules (RN)

Page 4: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Cavernous Hemangioma

• Large ones have typical appearance– Very intense on T2WI– Nodular peripheral enhancement

• Smaller (“capillary”) hemangiomas– May enhance homogeneously– Can be confused with HCC– Key is remaining isodense with vessels

Page 5: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

2 years later

Only found a “scar” in explant

Hemangioma in Cirrhotic Liver

• Shrinks to Fibrotic Scar

Page 6: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

HCC?

No! Cavernous Hemangioma

• Isodense to vessels

Page 7: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Focal Confluent Fibrosis

• Present in ~ 30% of advanced cirrhosis– > 50% of PSC

• Most common in anterior + medial segments– Usually wedge-shaped lesion

• 80% have focal volume loss– Capsular retraction, crowded vessels

• Low density on NCCT– Delayed persistent enhancement

• High intensity on T2 – MR– Can simulate tumor

Ohtomo et al. Radiology 1993; 188: 31-35Krinsky et al. Radiology 2001; 219: 445-454

Page 8: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Confluent Hepatic Fibrosis(Focal Confluent Fibrosis)

Federle: DI: Abdomen

• Present in ~ 30% of advanced cirrhosis– > 50% of PSC

• Most common in anterior + medial segments– Usually wedge-shaped lesion

• 80% have focal volume loss– Capsular retraction, crowded

vessels• Low density on NCCT

– Delayed persistent enhancement

• High intensity on T2 – MR– Can simulate tumor

Page 9: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Focal Confluent Fibrosis

Note delayed enhancement

Page 10: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Confluent Hepatic Fibrosis

Page 11: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

NC T1WI

HAPdelayed

MRI Confluent Hepatic Fibrosis

Page 12: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

T1 WI

T1 PVP

Confluent Hepatic Fibrosis

T2 WI

Page 13: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Peripheral Wedge-shaped Lesion• May appear central + round on axial section• Examples:• Focal confluent fibrosis• THADs• AP shunts

Page 14: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Focal Lesions in the Cirrhotic Liver

• Regenerative nodules (RN)

• Dysplastic nodules

• Hepatocellular carcinoma (HCC)

Page 15: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Evolution of (some) Cirrhotic Nodules(Sakamoto hypothesis, 1991)

Regenerative Nodule

High Grade Dysplastic Nodule

Low Grade Dysplastic Nodule

Well-Differentiated HCC

Overt HCC (Moderately/Poorly Differentiated)

Page 16: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Regenerating Nodules

• Usually too small to detect by imaging– May be surrounded by fibrotic septa– May contain iron, copper

• Siderotic nodules– Hyperdense on NCCT, disappear on HAP & PVP– Hypointense on T2 MR, “bloom” on GRE

• Larger or vascular/enhancing RN– Can not be distinguished from dysplastic nodule or

HCC

Page 17: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Regenerating Nodules

Page 18: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

NCCT

HAP

PVP

GRE

Cirrhotic Nodules• visible only on NCCT & GRE

Page 19: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

T1 WI

T2 WI

Best seen on T2 WI(hypointense, multiple)

Regenerating Nodules

Page 20: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

NCCT

HAP

PVP

Regenerating Nodules • hyperdense only on NECT

Page 21: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Regenerating Nodules • Importance of NCCT imaging• Don’t call “hypervasc. HCC”

Page 22: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

48 y/o man with cirrhosisRegenerating Nodules

Cavernous Hemangiomas

Page 23: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

48 y/o man with cirrhosis

Also has HCC

Must characterize lesions on all phases of CT or MR

Page 24: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Dysplastic Nodules

• “Adenomatous hyperplasia” (old term)• Are premalignant• Rarely diagnosed by US or CT• MR – iso to hyperintense on T1

– Hypo on T2 (opposite of HCC)– Should not enhance much on HAP– Diagnosed correctly 5 – 15% of cases

Krinsky et al. Radiology 2001; 219: 445-454

Dodd et al. AJR 1999; 173: 1185 - 1192

Page 25: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Dysplastic Nodules

T1WI T2WI

Hyper on T1Hypo on T2(opposite of HCC)

Page 26: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Focal NoduleLargeHyper on NECTMinimal vascularity

NECT

HAP

PVP

Page 27: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Focal NoduleBright on T1WINo signal loss on OOP(= not focal fat)Dark on T2 WIMinimal Vascularity

T2WI

T1WI-IP T1WI-OOP

Dysplastic Nodule

HAP

PVP

Delayed

Page 28: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Focal Nodule (same patient)Hypoechoic massUS-guided BxConfirmed dysplastic nodule

Courtesy: Mitch Tublin MDUPMC

Page 29: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Hepatocellular Carcinoma (HCC)

• Heterogeneously hypervascular mass

• Washes out on delayed phase

• Invades veins (portal > hepatic)

Federle: DI: Abdomen

Page 30: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

HCC - Helical CT

• Main imaging tool in most institutions• Must be multiphasic

– Arterial phase ~ 25 – 35 seconds• Dual arterial, or test bolus is ideal

– Portal venous ~ 60 – 70 seconds– Noncontrast

• Very helpful for RNs, cysts– Delayed or equilibrium

• Useful (but hard to justify 4 phase imaging)• Rapid injection (4 or 5 ml/sec); large volume

– (2 ml/kg; > 150 ml)

Page 31: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

HCC - Helical CT

• Allows detection and characterization of most masses > 2 cm diameter

• Accurately reflects morphology and hemodynamics of tumor– Small, well differentiated HCC

• Still have portal venous supply• Often hypo – to isodense on NC + HAP• Hypodense on PVP

– Capsule, fat common in well-differentiated– Most HCC (Best seen as hyperdense on HAP)

Page 32: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

HCC within Dysplastic Nodule• “nodule-in-nodule” pattern

(each component has typical features)

Page 33: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

NC PVP

Typical HCC• screening CT• chronic Hep C• isodense on NC + PVP

HAP HAP

Page 34: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Simplified Approach to Liver Hemodynamics

increased dysplasia = more arterial, less portal

RN Mod-diffHCC

0

20

40

60

80

100

Normal DysplasticNodule

Well-diffHCC

%

% arterial supply

% venous supply

Page 35: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

HCC moderately differentiated• best on HAP• “washes out” on PVP

NC

HAP

PVP

Page 36: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

HCC - only or best seen on HAP

Page 37: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

HCC with capsuleNC

HAP

PVP

Page 38: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

HCC well-differentiated• best on PVP

HAP

PVP

Page 39: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

HCC Mod Differentiated• Best on HAP

Page 40: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

PVPHAP

Small HCC• only seen on HAP & MR

Page 41: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

T1 NC

T1 PVP T2 WI

SmallHCCT1 HAP

Page 42: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

HCC• small tumor• PV invasion

Tumor Thrombus:•Contiguity w tumor•Expansion of lumen•Enhancing thrombus

Page 43: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

NECT

NECT

HAP

PVP

HCC: Other FeaturesFocal fatCalcifications

Lesion with Focal fat in cirrhotic liver= HCC

Page 44: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

= not seen (isodense, isointense)

= hyperdense (-intense) to liver

= hypointense (-intense) to liver

Regenerative

Nodule

Dysplastic

Nodule

Well-diff

HCC

Mod-diff

HCC

PVPHAPT1 T2DelayPVPHAPNC

or

or

or

or

or

or

or or

or

or

or

or

or

or

or

or

or

or

CT MR

Nodular Lesions in Cirrhosis

Page 45: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

HCC - Helical CT Accuracy

• Good for large tumors• Challenging in screening population

(asymptomatic, normal tumor markers)• We miss (false + and neg) small HCCs (<2cm)

frequently• However, we usually (> 95%, UPMC data)

accurately guide Rx – Decision for follow-up, ablation, TACE,

transplantation

Page 46: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

• Multidetector CT and dual arterial phase imaging

• Sensitivity (86%), positive pred value (92%)– Mean size of HCC (22 mm)

• Much better results than other reports

Murakami et al. Radiology 2001; 218: 763-767

HCC- Helical CT Accuracy

Page 47: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

HCC- MR Accuracy

• Variable intensity of HCC on T1 MR– 35% hyper -, 25% iso-, 40 % hypo– Hyperintense often well-differentiated,

contain fat• Almost always hyperintense on T2 MR• Must have multiphasic study after bolus of

Gd-DTPA– Most HCC are hypervascular/intense on

HAP

Page 48: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

HCC- MR Accuracy

• Best studies with good reference standard (OLT, explantation) in screening population– Detect HCC in 50 – 65% of patients– Detect 35 – 50% of HCC tumors– Miss many tumors 20 mm– Hard to distinguish some RNs and

dysplastic nodules

Krinsky et al. Radiology 2001; 219: 445-454

Page 49: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

HCC- Helical CT Pitfalls

• THAD (transient hep. attenuation differences)– Small peripheral wedge-shaped

• Ignore, usually due to AP shunt or aberrant veins

• Larger segmental or lobar– Often due to tumor occlusion of portal vein

• Arterioportal shunt – Common in cirrhosis– Usually benign if small, peripheral, non-spherical,

isodense on PVP, visible vessels into + out

Page 50: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

PVP

HAP

PVP

Lobar “THAD”• HCC obstructing RPV

Page 51: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

AP Shunt• no tumor• resolved spontaneously

Page 52: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

AP Shunt• ? Post-biopsy• visible vessels

Page 53: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

AP Shunt• spontaneous

Page 54: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

AP Shunts + Hemangioma • Shunts disappeared

• Hemangioma stable 3 yrs

Page 55: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

AP Shunt in CirrhosisEarly draining vein

Small AP shunts are common, often resolveDon’t be too aggressive with Dx or Rx

Page 56: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

HCC- Helical CT vs MR

• Comparable performance• MR preference

– Contrast allergy– Known steatosis

• CT preference– Ascites, unstable, tachypneic patient

• Both are evolving and improving (but often performed/interpreted poorly)

Page 57: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

• Pitt Experience with 430 transplant recipients– Excluding 2 patients with HCC + markedly

AFP– No significant difference in serum AFP in

HCC, non-HCC groups– AFP often normal in small HCC– AFP often elevated in flare of hepatitis

Peterson et al. Radiology 2000; 217: 743-749

Tumor Markers for HCC

Page 58: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Screening Recommendation for Known Cirrhosis

• AFP and PIVKA II – every 3 months• Ultrasonography – every 3 or 4 months• CT or MR – every 12 months• (for chronic hepatitis without cirrhosis,

extend intervals)• (for high clinical suspicion or indeterminate

lesion, shorten interval)

Page 59: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Summary

• US, CT, MR all useful in evaluation of cirrhosis

• Large and symptomatic HCCs are easily detected and staged

• Small HCCs in a screening population are more challenging– Some overlap in appearance of regenerative

+ dysplastic nodules + HCC

Page 60: Michael P. Federle, MD Associate Chair for Education Department of Radiology Stanford University Focal Lesions in the Cirrhotic Liver.

Summary

• Optimal CT + MR techniques are key

– Must include multiple phases, rapid bolus contrast administration

• Image-guided Bx and angiography often necessary